2024-03-28 21:03:08 ET
Achieve Life Sciences, Inc. (ACHV)
Q4 2023 Earnings Conference Call
March 28, 2024 4:30 PM ET
Company Participants
Nicole Jones – Investor Relations
John Bencich – Chief Executive Officer
Cindy Jacobs – President and Chief Medical Officer
Jerry Wan – Principal Accounting Officer
Conference Call Participants
Thomas Flaten – Lake Street Capital
Francois Brisebois – Oppenheimer and Company
Michael Higgins – Ladenburg Thalmann
John Vandermosten – Zacks
Ilya Zubkov – Freedom Broker
Presentation
Operator
Greetings. Welcome to the Achieve Life Sciences Fourth Quarter and Year-End 2023 Earnings Conference Call and Webcast. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded.
I would like to hand the call over to Nicole Jones, Investor Relations. Thank you. You may begin.
Nicole Jones
Thank you, operator. Good afternoon, everyone, and thank you for joining us today. From Achieve Life Sciences, we are joined by John Bencich, Chief Executive Officer; Dr. Cindy Jacobs, President and Chief Medical Officer; and Jerry Wan, Principal Accounting Officer. Management will be available for a Q&A session following today’s prepared remarks.
I’d like to remind everyone that today’s conference call contains forward-looking statements based on current expectations. These statements are only predictions and actual results may vary materially from those projected. Please refer to Achieve documents available on our website and filed with the SEC concerning factors that may affect the company....
Read the full article on Seeking Alpha
For further details see:
Achieve Life Sciences, Inc. (ACHV) Q4 2023 Earnings Call Transcript